Fijnvandraat K - Search Results

1

Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening.

van der Plas EM, van den Tweel XW, Geskus RB, Heijboer H, Biemond BJ, Peters M, Fijnvandraat K. van der Plas EM, et al. Among authors: fijnvandraat k. Br J Haematol. 2011 Oct;155(1):106-10. doi: 10.1111/j.1365-2141.2011.08806.x. Epub 2011 Jul 27. Br J Haematol. 2011. PMID: 21793816 Free article.

2

Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.

Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJ, ten Cate JW. Fijnvandraat K, et al. Thromb Haemost. 1995 Jan;73(1):15-20. Thromb Haemost. 1995. PMID: 7740486

3

Endotoxin induced coagulation activation and protein C reduction in meningococcal septic shock.

Fijnvandraat K, Peters M, Derkx B, van Deventer S, ten Cate JW. Fijnvandraat K, et al. Prog Clin Biol Res. 1994;388:247-54. Prog Clin Biol Res. 1994. PMID: 7831362 Review. No abstract available.

4

Inter-individual variation in half-life of infused recombinant factor VIII is related to pre-infusion von Willebrand factor antigen levels.

Fijnvandraat K, Peters M, ten Cate JW. Fijnvandraat K, et al. Br J Haematol. 1995 Oct;91(2):474-6. doi: 10.1111/j.1365-2141.1995.tb05325.x. Br J Haematol. 1995. PMID: 8547097 Clinical Trial.

5

Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock.

Wuillemin WA, Fijnvandraat K, Derkx BH, Peters M, Vreede W, ten Cate H, Hack CE. Wuillemin WA, et al. Among authors: fijnvandraat k. Thromb Haemost. 1995 Dec;74(6):1436-41. Thromb Haemost. 1995. PMID: 8772216

6

Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients.

Fijnvandraat K, Berntorp E, ten Cate JW, Johnsson H, Peters M, Savidge G, Tengborn L, Spira J, Stahl C. Fijnvandraat K, et al. Thromb Haemost. 1997 Feb;77(2):298-302. Thromb Haemost. 1997. PMID: 9157585 Clinical Trial.

7

Acquired protein S deficiency caused by estrogen treatment of tall stature.

van Ommen CH, Fijnvandraat K, Vulsma T, Delemarre-Van De Waal HA, Peters M. van Ommen CH, et al. Among authors: fijnvandraat k. J Pediatr. 1999 Oct;135(4):477-81. doi: 10.1016/s0022-3476(99)70171-x. J Pediatr. 1999. PMID: 10518082

8

Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain.

van den Brink EN, Turenhout EA, Bank CM, Fijnvandraat K, Peters M, Voorberg J. van den Brink EN, et al. Among authors: fijnvandraat k. Blood. 2000 Jul 15;96(2):540-5. Blood. 2000. PMID: 10887116 Free article.

9

The impact of unaware carriership on the clinical presentation of haemophilia.

MacLean PE, Fijnvandraat K, Beijlevelt M, Peters M. MacLean PE, et al. Among authors: fijnvandraat k. Haemophilia. 2004 Sep;10(5):560-4. doi: 10.1111/j.1365-2516.2004.00955.x. Haemophilia. 2004. PMID: 15357784

10

Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptoms.

van den Tweel X, Heijboer H, Fijnvandraat K, Peters M. van den Tweel X, et al. Among authors: fijnvandraat k. Eur J Pediatr. 2006 Aug;165(8):581-2. doi: 10.1007/s00431-006-0102-7. Epub 2006 Apr 29. Eur J Pediatr. 2006. PMID: 16649026 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters